Global Anti-Suicide Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published On: January 2019 | Report ID: 137154 | Category: Pharmaceuticals and HealthcarePages: 137

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician.

Scope of the Report:

This report focuses on the Anti-Suicide Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Anti-Suicide Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 4610 million US$ in 2023, from 3600 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Pfizer

AstraZeneca plc

Eli Lilly and Company

Allergan plc

GlaxoSmithKline plc

Merck & Co., Inc

H. Lundbeck A/S

NeuroRx, Inc

Johnson & Johnson

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Anti-Depressants and Anti-Anxiety Drugs

Anti-Psychotic Drugs

NMDA Antagonist

Antibiotic Analog

Market Segment by Applications, can be divided into

Hospitals

Retail pharmacies

Online pharmacies

There are 15 Chapters to deeply display the global Anti-Suicide Drugs market.

Chapter 1, to describe Anti-Suicide Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti-Suicide Drugs, with sales, revenue, and price of Anti-Suicide Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti-Suicide Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti-Suicide Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti-Suicide Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Anti-Suicide Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Anti-Depressants and Anti-Anxiety Drugs

1.2.2 Anti-Psychotic Drugs

1.2.3 NMDA Antagonist

1.2.4 Antibiotic Analog

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Retail pharmacies

1.3.3 Online pharmacies

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Anti-Suicide Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca plc

2.2.1 Business Overview

2.2.2 Anti-Suicide Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca plc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly and Company

2.3.1 Business Overview

2.3.2 Anti-Suicide Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly and Company Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Allergan plc

2.4.1 Business Overview

2.4.2 Anti-Suicide Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Allergan plc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 GlaxoSmithKline plc

2.5.1 Business Overview

2.5.2 Anti-Suicide Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 GlaxoSmithKline plc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Merck & Co., Inc

2.6.1 Business Overview

2.6.2 Anti-Suicide Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Merck & Co., Inc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 H. Lundbeck A/S

2.7.1 Business Overview

2.7.2 Anti-Suicide Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 H. Lundbeck A/S Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 NeuroRx, Inc

2.8.1 Business Overview

2.8.2 Anti-Suicide Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 NeuroRx, Inc Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Johnson & Johnson

2.9.1 Business Overview

2.9.2 Anti-Suicide Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Johnson & Johnson Anti-Suicide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Anti-Suicide Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Anti-Suicide Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Anti-Suicide Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Anti-Suicide Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Anti-Suicide Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Anti-Suicide Drugs Market Analysis by Regions

4.1 Global Anti-Suicide Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Anti-Suicide Drugs Sales and Market Share by Regions (2013-2018)

4.1.2 Global Anti-Suicide Drugs Revenue and Market Share by Regions (2013-2018)

4.2 North America Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

4.3 Europe Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

4.5 South America Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

5 North America Anti-Suicide Drugs by Countries

5.1 North America Anti-Suicide Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)

5.1.2 North America Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)

5.2 United States Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

5.3 Canada Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

5.4 Mexico Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

6 Europe Anti-Suicide Drugs by Countries

6.1 Europe Anti-Suicide Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)

6.2 Germany Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

6.3 UK Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

6.4 France Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

6.5 Russia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

6.6 Italy Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Anti-Suicide Drugs by Countries

7.1 Asia-Pacific Anti-Suicide Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)

7.2 China Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

7.3 Japan Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

7.4 Korea Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

7.5 India Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

8 South America Anti-Suicide Drugs by Countries

8.1 South America Anti-Suicide Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)

8.1.2 South America Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

8.3 Argentina Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

8.4 Colombia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Anti-Suicide Drugs by Countries

9.1 Middle East and Africa Anti-Suicide Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Anti-Suicide Drugs Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Anti-Suicide Drugs Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

9.3 UAE Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

9.4 Egypt Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

9.5 Nigeria Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

9.6 South Africa Anti-Suicide Drugs Sales and Growth Rate (2013-2018)

10 Global Anti-Suicide Drugs Market Segment by Type

10.1 Global Anti-Suicide Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Anti-Suicide Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Anti-Suicide Drugs Revenue and Market Share by Type (2013-2018)

10.2 Anti-Depressants and Anti-Anxiety Drugs Sales Growth and Price

10.2.1 Global Anti-Depressants and Anti-Anxiety Drugs Sales Growth (2013-2018)

10.2.2 Global Anti-Depressants and Anti-Anxiety Drugs Price (2013-2018)

10.3 Anti-Psychotic Drugs Sales Growth and Price

10.3.1 Global Anti-Psychotic Drugs Sales Growth (2013-2018)

10.3.2 Global Anti-Psychotic Drugs Price (2013-2018)

10.4 NMDA Antagonist Sales Growth and Price

10.4.1 Global NMDA Antagonist Sales Growth (2013-2018)

10.4.2 Global NMDA Antagonist Price (2013-2018)

10.5 Antibiotic Analog Sales Growth and Price

10.5.1 Global Antibiotic Analog Sales Growth (2013-2018)

10.5.2 Global Antibiotic Analog Price (2013-2018)

11 Global Anti-Suicide Drugs Market Segment by Application

11.1 Global Anti-Suicide Drugs Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Retail pharmacies Sales Growth (2013-2018)

11.4 Online pharmacies Sales Growth (2013-2018)

12 Anti-Suicide Drugs Market Forecast (2018-2023)

12.1 Global Anti-Suicide Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Anti-Suicide Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Anti-Suicide Drugs Market Forecast (2018-2023)

12.2.2 Europe Anti-Suicide Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Anti-Suicide Drugs Market Forecast (2018-2023)

12.2.4 South America Anti-Suicide Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Anti-Suicide Drugs Market Forecast (2018-2023)

12.3 Anti-Suicide Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Anti-Suicide Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Anti-Suicide Drugs Market Share Forecast by Type (2018-2023)

12.4 Anti-Suicide Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Anti-Suicide Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Anti-Suicide Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@mrinsights.biz

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.